Phosphoinositide 3-kinase in disease: timing, location, and scaffolding

被引:169
作者
Wymann, MP [1 ]
Marone, R [1 ]
机构
[1] Univ Basel, Biomed Ctr, Dept Clin & Biol Sci, Inst Biochem & Genet, CH-4058 Basel, Switzerland
关键词
D O I
10.1016/j.ceb.2005.02.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
When PI3Ks are deregulated by aberrant surface receptors or modulators, accumulation of PtdIns(3,4,5)P-3 leads to increased cell growth, proliferation and contact-independent survival. The PI3K/PKB/TOR axis controls protein synthesis and growth, while PtdIns(3,4,5)P-3-mediated activation of Rho GTPases directs cell motility. PI3K activity has been linked to the formation of tumors, metastasis, chronic inflammation, allergy and cardiovascular disease. Although increased PtdIns(3,4,5)P-3 is a well-established cause of disease, it is seldom known which PI3K isoform is implied. Recent work has demonstrated that PI3K gamma contributes to the control of cAMP levels in the cardiac system, where the protein acts as a scaffold, but not as a lipid kinase.
引用
收藏
页码:141 / 149
页数:9
相关论文
共 62 条
  • [1] Bcr-Abl variants:: biological and clinical aspects
    Advani, AS
    Pendergast, AM
    [J]. LEUKEMIA RESEARCH, 2002, 26 (08) : 713 - 720
  • [2] The biology of Kit in disease and the application of pharmacogenetics
    Akin, C
    Metcalfe, DD
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (01) : 13 - 19
  • [3] Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity
    Ali, IU
    Schriml, LM
    Dean, M
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (22): : 1922 - 1932
  • [4] Essential role for the p110δ phosphoinositide 3-kinase in the allergic response
    Ali, K
    Bilancio, A
    Thomas, M
    Pearce, W
    Gilfillan, AM
    Tkaczyk, C
    Kuehn, N
    Gray, A
    Giddings, J
    Peskett, E
    Fox, R
    Bruce, I
    Walker, C
    Sawyer, C
    Okkenhaug, K
    Finan, P
    Vanhaesebroeck, B
    [J]. NATURE, 2004, 431 (7011) : 1007 - 1011
  • [5] Topical treatment with inhibitors of the phosphatidylinositol 3′-kinase/akt and raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways reduces melanoma development in severe combined immunodericient mice
    Bedogni, B
    O'Neill, MS
    Welford, SM
    Bouley, DM
    Giaccia, AJ
    Denko, NC
    Powell, MB
    [J]. CANCER RESEARCH, 2004, 64 (07) : 2552 - 2560
  • [6] A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cells
    Bénistant, C
    Chapuis, H
    Roche, S
    [J]. ONCOGENE, 2000, 19 (44) : 5083 - 5090
  • [7] Rho GTPases in human cancer:: an unresolved link to upstream and downstream transcriptional regulation
    Benitah, SA
    Valerón, PF
    van Aelst, L
    Marshall, CJ
    Lacal, JC
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2004, 1705 (02): : 121 - 132
  • [8] Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles
    Berwick, DC
    Dell, GC
    Welsh, GI
    Heesom, KJ
    Hers, I
    Fletcher, LM
    Cooke, FT
    Tavaré, JM
    [J]. JOURNAL OF CELL SCIENCE, 2004, 117 (25) : 5985 - 5993
  • [9] Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions
    Biondi, RM
    Nebreda, AR
    [J]. BIOCHEMICAL JOURNAL, 2003, 372 : 1 - 13
  • [10] The TOR pathway: A target for cancer therapy
    Bjornsti, MA
    Houghton, PJ
    [J]. NATURE REVIEWS CANCER, 2004, 4 (05) : 335 - 348